GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr | ₹-675 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹2.09 Cr |
| Mar2024 | ₹4,561 Cr |
| Mar2023 | ₹-528 Cr |
| Mar2022 | ₹-333 Cr |
| Mar2021 | ₹-675 Cr |
How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.09 Cr | -99.95 | |
| Mar2024 | ₹4,561 Cr | Positive | |
| Mar2023 | ₹-528 Cr | Negative | |
| Mar2022 | ₹-333 Cr | Negative | |
| Mar2021 | ₹-675 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹67,097.3 Cr | 5.6% | 7% | 62.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5.6% |
7% |
62.2% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses